Whang R, Hampton E M, Whang D D
Veterans Affairs (VA) Medical and Regional Office Center, Honolulu, HI.
Ann Pharmacother. 1994 Feb;28(2):220-6. doi: 10.1177/106002809402800213.
To survey the causes of clinical hypomagnesemia and Mg deficiency. The relationship of hypomagnesemia to digitalis toxicity, congestive heart failure, arrhythmias, and acute myocardial infarction is discussed, as is the clinical interrelationship of Mg and K concentrations, the principal intracellular cations.
A MEDLINE search and retrieval was used to identify relevant references.
Clinical reports, as well as studies, were selected for this review.
There were very few placebo-controlled clinical studies. Clinical observations were related primarily to compilation of series in which Mg was administered and clinical results reported. In addition, conclusions derived from review articles on the subject of clinical Mg depletion were used.
Clinical diagnosis of Mg deficiency is ascertained most expeditiously by estimating serum Mg concentrations. Although available on order by physicians, the lack of routine serum Mg analysis as part of the "electrolyte panel" impedes the diagnosis of clinical Mg deficiency. Renal loss of Mg resulting from the widespread use of loop diuretics is responsible for significant numbers of patients with Mg deficiency and hypomagnesemia. Life-threatening cardiac arrhythmias and seizures represent the most serious manifestations of clinical hypomagnesemia and Mg depletion. In the most critically ill patients, treatment with intravenous Mg is recommended. Oral repletion of Mg is reserved for the less critically ill hospitalized patients and ambulatory patients. Close attention must be paid to optimizing K replenishment in hypokalemic patients by concurrent treatment of any accompanying hypomagnesemia to avoid the problem of refractory K repletion.
Hypomagnesemia is one of the most frequent serum electrolyte abnormalities in current clinical practice. Routine inclusion of serum Mg analysis in the electrolyte panel will enhance the clinical recognition and treatment of hypomagnesemic Mg-depleted patients. Failure to respond to treatment of recurrent ventricular tachycardia/fibrillation to usual antiarrhythmic therapy in patients with acute myocardial infarction, idiopathic dilated cardiomyopathy, and congestive heart failure should alert the clinician to consider administering intravenous Mg. Repair of coexisting hypomagnesemia in hypokalemic patients is essential to avoid the problem of refractory K repletion caused by coexisting Mg depletion. More controlled clinical studies of Mg deficiency are necessary to ascertain the cost-effectiveness of Mg replacement therapy.
调查临床低镁血症和镁缺乏的原因。讨论低镁血症与洋地黄毒性、充血性心力衰竭、心律失常及急性心肌梗死的关系,以及镁与钾(主要的细胞内阳离子)浓度的临床相互关系。
使用MEDLINE检索和获取相关参考文献。
本次综述选择了临床报告及研究。
几乎没有安慰剂对照的临床研究。临床观察主要涉及对给予镁剂并报告临床结果的系列病例的汇总。此外,还采用了关于临床镁缺乏主题的综述文章得出的结论。
通过估算血清镁浓度能最迅速地确定镁缺乏的临床诊断。尽管医生可按需进行检测,但作为“电解质检查项目”的一部分,缺乏常规血清镁分析阻碍了临床镁缺乏的诊断。广泛使用袢利尿剂导致的肾脏排镁是大量镁缺乏和低镁血症患者的病因。危及生命的心律失常和癫痫是临床低镁血症和镁缺乏最严重的表现。对于病情最危重的患者,建议静脉补充镁。口服补充镁适用于病情较轻的住院患者和门诊患者。低钾血症患者必须密切关注通过同时治疗任何伴发的低镁血症来优化钾补充,以避免难治性补钾问题。
低镁血症是当前临床实践中最常见的血清电解质异常之一。将血清镁分析常规纳入电解质检查项目将提高对低镁血症和镁缺乏患者的临床识别和治疗水平。急性心肌梗死、特发性扩张型心肌病和充血性心力衰竭患者对常规抗心律失常治疗的复发性室性心动过速/颤动治疗无反应时,临床医生应警惕考虑给予静脉镁剂。纠正低钾血症患者并存的低镁血症对于避免因并存镁缺乏导致的难治性补钾问题至关重要。需要更多关于镁缺乏的对照临床研究来确定镁替代疗法的成本效益。